EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn't Buy This Merger Talk
Systemic Lupus Erythematosus Market Report Now Available - Segments Biologics, Small Molecules, Drug Classes, Administration Routes, and Therapy Types
Nanomedicine Market Report Examines Products, Services and Growth Opportunities Through 2030
Rural pharmacies identify thousands of patients at risk of stroke, heart disease, pilot program reveals
Bristol Myers to build $2.3 billion manufacturing site in Houston
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
Bristol Myers Squibb to build $2.3 billion Houston campus
Americas Cancer Immunotherapy Market to Reach $125.32 Billion by 2031, Driven by R&D Advances and Expanding Clinical Adoption
Bristol Myers Squibb to Build $2.3 Billion Campus in Houston
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
Next Level Private LLC Increases Position in Bristol Myers Squibb Company $BMY - Stock Observer
Decade-long persistence of CD19 CAR T cells in B cell lymphomas
NewEdge Advisors LLC Has $13.71 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Birchbrook Inc. Sells 15,107 Shares of Bristol Myers Squibb Company $BMY - Daily Political
MRA Advisory Group Buys Shares of 23,652 Bristol Myers Squibb Company $BMY
Rockland Trust Co. Has $8.47 Million Holdings in Bristol Myers Squibb Company $BMY
MRA Advisory Group Buys New Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Foresight Capital Management Advisors Inc. Purchases 11,774 Shares of Bristol Myers Squibb Company $BMY - Daily Political
CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong
Cancer Monoclonal Antibodies Market Size & Share Analysis | Growth Trends and Forecasts (2026- 2031) | Covers Five Global Regions
Czech National Bank Purchases 26,627 Shares of Bristol Myers Squibb Company $BMY
How the FTSE became a 'departure lounge' for British companies
Replimune Wins FDA Accelerated Nod For TUDRIQEV In Advanced Melanoma
Replimune Wins FDA Accelerated Nod For TUDRIQEVTM In Advanced Melanoma
AI-based augmentation of oncology clinical trials
Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Canandaigua National Bank & Trust Co. Takes Position in Bristol Myers Squibb Company $BMY
High-Stakes 100-Billion-Yuan Mega Investment Gamble Unfolds: What's Next for the Trillion-Scale Economic Bet?
Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift - Has The Bull Case Changed?
AstraZeneca and Bristol Myers Squibb: No Ongoing Merger Discussions Confirmed, ETPharma
Prediction: AbbVie Will End The Year at This Price
AstraZeneca and Bristol Myers Squibb merger talks denied
Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
Analyst Report: Bristol-Myers Squibb Co
Bristol Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Argus - Daily Political
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group
Promising Dividend Stocks To Watch Today - August 4th - Stock Observer
Brokers split on AstraZeneca merger talk as shares recover some ground
BioNTech Q2 Earnings Call Highlights
Hilltop National Bank Invests $1.44 Million in Astrazeneca Plc $AZN
Hilltop National Bank Buys Shares of 7,577 Astrazeneca Plc $AZN - Stock Observer
Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?
UK's AstraZeneca eyeing $400b merger, report says - World - Chinadaily.com.cn
Navigating evidence-based recommendations for the management of systemic sclerosis
European shares start August higher on US-Iran diplomacy hopes
Amazon joins US$3t market cap club as cheaper oil buoys market
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today
AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks
Dow Jones Top Company Headlines at 1 PM ET: Rising Beef Costs Pressure Tyson's Bottom Line | Lantheus ... | Morningstar
Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could "Cut Costs in a Big Way"
AstraZeneca-Bristol Myers Squibb merger 'is not highly likely to happen,' says UBS' Michael Yee
Astrazeneca (NYSE:AZN) Shares Gap Down - Should You Sell? - Markets Daily
AstraZeneca Slides 8% On Report Of Potential Bristol Myers Merger Talks
AstraZeneca and Bristol-Myers Squibb: Megamerger Reports Leave Us Scratching Our Heads | Morningstar
Bristol Myers Squibb (NYSE:BMY) Sets New 12-Month High After Analyst Upgrade
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca
Live Nasdaq Composite: Stock Market Bulls Wrestle Control to Start August as Oil Drops 6%
An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it 'odd' | Morningstar
Astrazeneca (NYSE:AZN) Shares Gap Down - Here's Why - Stock Observer
A $400 Billion Pharma Deal Could Get Really Messy: Chris Hughes
AstraZeneca Weighs a Deal Its CEO Said It Didn't Need
Report: AstraZeneca explores tie-up with Bristol Myers Squibb
Stocks making the biggest moves premarket: BABA, BMY, EBAY & more
Dow Jones Top Company Headlines at 7 AM ET: AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports | Banco ... | Morningstar
AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. | Morningstar
AstraZeneca shares sink 7% on report of historic $400 billion merger talks with Bristol Myers Squibb
Morgan Stanley uncovers major Bristol Myers stock signals
North American Morning Briefing: Stock Futures Up, Oil Slumps After Trump Calls Off Iran Attack | Morningstar
Hamilton Wealth LLC Lowers Stake in Bristol Myers Squibb Company $BMY
AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports - Update | Morningstar
Bristol Myers Squibb Company $BMY Stake Lowered by Pacer Advisors Inc.
Rathbones Group PLC Has $1.56 Billion Stock Holdings in Astrazeneca Plc $AZN - Markets Daily
U.S. Stock Futures Rise, Oil Falls as U.S. Shifts Toward Diplomacy with Iran | Morningstar
| Country News
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks | Morningstar
Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca
AstraZeneca shares tumble 7% after reported Bristol Myers talks
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
AstraZeneca in talks over £300bn mega-merger with US rival - reports
AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources | Morningstar
AstraZeneca and Bristol Myers Squibb Explore $400 Billion Merger Talks, ETPharma
AstraZeneca And Bristol Myers Reportedly In Talks On $400 Bln Deal
AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says
AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
AstraZeneca and Bristol-Myers Squibb in talks over potential merger - Report
AstraZeneca plots £300bn tie-up with US rival
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
AstraZeneca, Bristol Myers Squibb Held Talks for Tie-Up, FT Says
Bristol-Myers Squibb Company Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Caerus Investment Advisors LLC Reduces Holdings in Bristol Myers Squibb Company $BMY - Zolmax
Latest news
Show more
Gold Price Today, August 12, 2026: XAU/USD Rises 0.5% Near $4,400 Ahead of US CPI
Oil Nears $90 as Fading U.S.-Iran Deal Hopes Renew Hormuz Supply Fears
Supermicro Stock Rallies as Margin Recovery and FY2027 Outlook Eclipse Q4 Revenue Miss
USD to JPY Exchange Rate May Have Peaked, Eurizon Sees Yen Strengthening to 125
NIO Stock News Today: Shares Slide as BlackRock Trims Stake Despite Record ES9 Demand
